The Effect of Estradiol on Renal Function in Reversible and Irreversible Unilateral Ureteral Obstruction in Rats

Zahra Lak, Akbar Vahdati, Mehdi Nematbakhsh

Abstract


BACKGROUND: The ureteral obstruction (UO) is the most common clinical disorders. This study was designed to investigate the renoprotective effect of estradiol in unilateral UO (UUO) and reversible UUO (RUUO).

METHODS: Eighty-four ovareictomized Wistar rats were assigned into 14 groups. Group 1 was sham operated group. All the groups 2-14 were subject to UUO, however they received additional treatments. Group 2-4 received test substances (vehicle, 0.1 or 0.05 mg/kg of estradiol) and sacrificed after 3 days. Group 5-7 received test substances and after 3 days followed by RUUO (obstruction removal) and after one day post RUUO were sacrificed. Group 8-9 followed by RUUO after 3 days and simultaneously received estradiol and after one day post RUUO were sacrificed. Group 10-12 followed by RUUO after 3 days and simultaneously received test substances and after 3 days post RUUO were sacrificed. Group 13-14 received test substances followed by RUUO and received test substances again and after 3 days post RUUO were sacrificed.

RESULTS: The estradiol reduced body weight significantly (p<0.05) in UUO, and the uterus weight (UW) increased significantly by estradiol (p<0.05). The increased serum levels of blood urea nitrogen (BUN) and creatinine (Cr), and kidney weight (KW) induced by UUO (p<0.05) were not attenuated by estradiol. Estradiol treatment did not alter the levels of BUN, Cr, KW, Cr clearance (CrCl), urine sodium excretion and urine flow when compared with control.

CONCLUSION: Although the protective role of estradiol in cardiovascular system is well accepted, however our findings suggest that its protection during UUO or after RUUO in renal system cannot be certain.

KEYWORDS: estradiol, ureteral obstruction, renal function, rat


Full Text:

PDF

References


Klahr S. New insights into the consequences and mechanisms of renal impairment in obstructive nephropathy. Am J Kidney Dis. 1991; 18: 689-99, CrossRef.

Klahr S, Purkerson ML. The pathophysiology of obstructive nephropathy: The role of vasoactive compounds in the hemodynamic and structural abnormalities of the obstructed kidney. Am J Kidney Dis. 1994; 23: 219-23, CrossRef.

Klahr S, Harris K, Purkerson ML. Effects of obstruction on renal functions. Pediatr Nephrol. 1988; 2: 34-42, CrossRef.

Buerkert J, Martin D, Head M, Prasad J, Klahr S. Deep nephron function after release of acute unilateral ureteral obstruction in the young rat. J Clin Invest. 1978; 62: 1228-39, CrossRef.

Dendooven A, Ishola Jr DA, Nguyen TQ, Van der Giezen DM, Kok RJ, Goldschmeding R, et al. Oxidative stress in obstructive nephropathy. Int J Clin Exp Pathol. 2011; 92: 202-10, CrossRef.

Cherikh W, Young C, Kramer B, Taranto S, Randall H, Fan PY. Ethnic and gender related differences in the risk of end-stage renal disease after living kidney donation. Am J Transplant. 2011; 11:1650-5, CrossRef.

Puri TS, Shakaib MI, Chang A, Mathew L, Olayinka O, Minto AW, et al. Chronic kidney disease induced in mice by reversible unilateral ureteral obstruction is dependent on genetic background. Am J Physiol Renal Physiol. 2010; 298: F1024-32, CrossRef.

Mao S, Xu H, Zou L, Xu G, Wu Z, Ding Q, et al. Estrogen preserves split renal function in a chronic complete unilateral ureteral obstruction animal model. Exp Ther Med. 2014;7: 1555-62, CrossRef.

Fung MM, Poddar S, Bettencourt R, Jassal SK, Barrett-Connor E. A cross-sectional and 10-year prospective study of postmenopausal estrogen therapy and blood pressure, renal function, and albuminuria: the Rancho Bernardo Study. Menopause. 2011; 18: 629-37, CrossRef.

Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA. Campbell-Walsh Urology: Expert Consult Premium Edition: Enhanced Online Features and Print, 4-volume set. New York: Elsevier; 2011.

Gillenwater J. The pathophysiology of urinary tract obstruction. In: Singh I, Strandhoy JW, Assimos DG. Campbell's Urology. New York: Elsevier; 1992. p.497-532, NLMID.

Jun L, Tong G, Xu F, Renjie Z. Effect of salvianolic acid A and C compatibility on inflammatory cytokines in rats with unilateral ureteral obstruction. J Tradit Chin Med. 2015; 35: 564-70, article.

Li C, Wang W, Kwon TH, Knepper MA, Nielsen S, Frøkiær J. Altered expression of major renal Na transporters in rats with unilateral ureteral obstruction. Am J Physiol Renal Physiol. 2003; 284: F155-66, CrossRef.

Topcu SO, Nørregaard R, Pedersen M, Wang G, Jørgensen TM, Frøkiær J. Regulation of aquaporins and sodium transporter proteins in the solitary kidney in response to partial ureteral obstruction in neonatal rats. Urol Int. 2011; 87: 94-104, CrossRef.

Shen Y, Miao N, Xu J, Gan X, Xu D, Zhou L, et al. Metformin prevents renal fibrosis in mice with unilateral ureteral obstruction and inhibits Ang II-induced ECM production in renal fibroblasts. Int J Mol Sci. 2016; 17: 146, CrossRef.

Liu H, Li W, He Q, Xue J, Wang J, Xiong C, et al. Mass spectrometry imaging of kidney tissue sections of rat subjected to unilateral ureteral obstruction. Sci Rep. 2017; 7: 41954, CrossRef.

Hassanshahi J, Maleki M, Nematbakhsh M. Renin-angiotensin system and unilateral ureteral obstruction. Physiol Pharmacol. 2017: 21: 266-78, article.

Hassanshahi J, Maleki M, Nematbakhsh M. Renal blood flow and vascular resistance responses to angiotensin II in irreversible and reversible unilateral ureteral obstruction rats; the role of angiotensin II type 1 and 2 receptors. J Nephropathol. 2018; 7: 57-64, CrossRef.

Hvistendahl JJ, Pedersen TS, Djurhuus JC, Pedersen EB, Frøkiær J. Losartan attenuates renal vasoconstriction in response to acute unilateral ureteral occlusion in pigs. Urol Res. 2002; 30: 169-77, CrossRef.

Durvasula RV, Petermann AT, Hiromura K, Blonski M, Pippin J, Mundel P, et al. Activation of a local tissue angiotensin system in podocytes by mechanical strain1. Kidney Int. 2004; 65: 30-9, CrossRef.

Negulescu O, Bognar I, Lei J, Devarajan P, Silbiger S, Neugarten J. Estradiol reverses TGF-β1-induced mesangial cell apoptosis by a casein kinase 2-dependent mechanism. Kidney Int. 2002; 62: 1989-98, CrossRef.

Álvarez Á, Hermenegildo C, Issekutz AC, Esplugues JV, Sanz MJ. Estrogens inhibit angiotensin II-induced leukocyte-endothelial cell interactions in vivo via rapid endothelial nitric oxide synthase and cyclooxygenase activation. Circ Res. 2002; 91: 1142-50, CrossRef.

Mori M, Tsukahara F, Yoshioka T, Irie K, Ohta H. Suppression by 17β-estradiol of monocyte adhesion to vascular endothelial cells is mediated by estrogen receptors. Life Sci. 2004; 75: 599-609, article.

Chevalier RL, Kim A, Thornhill BA, Wolstenholme JT. Recovery following relief of unilateral ureteral obstruction in the neonatal rat. Kidney Int. 1999; 55: 793-807, CrossRef.

Ito K, Chen J, El Chaar M, Stern JM, Seshan SV, Khodadadian JJ, et al. Renal damage progresses despite improvement of renal function after relief of unilateral ureteral obstruction in adult rats. Am J Physiol Renal Physiol. 2004; 287: F1283-93, CrossRef.

Hassanshahi J, Nematbakhsh M. The role of Mas receptor on renal hemodynamic responses to angiotensin 1-7 in both irreversible and reversible unilateral ureteral obstruction rats. Adv Biomed Res. 2018; 7: 12, CrossRef.

Gheissari A, Nematbakhsh M, Amir-Shahkarami SM, Alizadeh F, Merrikhi A. Glomerular filtration rate and urine osmolality in unilateral ureteropelvic junction obstruction. Adv Biomed Res. 2013; 2: 78, CrossRef.

Chevalier RL, Thornhill BA, Chang AY. Unilateral ureteral obstruction in neonatal rats leads to renal insufficiency in adulthood. Kidney Int. 2000; 58: 1987-95, CrossRef.




DOI: https://doi.org/10.18585/inabj.v10i3.459

Indexed by:

                 

                  

               

     

 

The Prodia Education and Research Institute